Vanguard Group Inc Hepion Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

  • $5.12 Trillion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.27 - $11.9 $447 - $19,718
1,657 Added 0.05%
3,310,180 $993,000
Q1 2022

May 13, 2022
SELL
$0.93 - $1.29 $16,269 - $22,567
-17,494 Reduced 0.53%
3,308,523 $4.27 Million
Q4 2021

Feb 14, 2022
SELL
$1.14 - $1.58 $5,385 - $7,463
-4,724 Reduced 0.14%
3,326,017 $3.79 Million
Q2 2021

Aug 13, 2021
BUY
$1.56 - $2.26 $5.2 Million - $7.53 Million
3,330,741 New
3,330,741 $6.6 Million

About Hepion Pharmaceuticals, Inc.

HEPA Quotes by TradingView
  • Ticker HEPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,229,600
  • Market Cap $45.7M
  • Description
  • Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...
More about HEPA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email